We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Persion Petitions FDA to Raise the Safety Bar for Extended Release Opioid
Persion Petitions FDA to Raise the Safety Bar for Extended Release Opioid
Persion Pharmaceuticals has petitioned the FDA to ensure that generics of its Zohydro ER hydrocodone bitartrate extended-release capsules prove their bioequivalence in patients with hepatic impairment.